INTERNATIONAL PATENT: CSPC ZHONGQI PHARMACEUTICAL TECHNOLOGY (SHIJIAZHUANG) CO., LTD., 石药集团中奇制药技术（石家庄）有限公司 FILES APPLICATION FOR "DUAL-TARGET NUCLEIC ACID MOLECULE FOR INHIBITING EXPRESSION OF VEGFA GENE AND ANG-2 GENE"

GENEVA, Dec. 8 -- CSPC ZHONGQI PHARMACEUTICAL TECHNOLOGY (SHIJIAZHUANG) CO., LTD. (No. 896, Zhongshan East Road, High-tech Zone,Shijiazhuang, Hebei 050035), 石药集团中奇制药技术（石家庄）有限公司 (中国河北省石家庄市高新区中山东路896号) filed a patent application (PCT/CN2025/098085) for "DUAL-TARGET NUCLEIC ACID MOLECULE FOR INHIBITING EXPRESSION OF VEGFA GENE AND ANG-2 GENE" on May 29, 2025. With publication no. WO/2025/247332, the details related to the patent application was published on Dec 04, 2025.

Notably, the patent appl...